155 related articles for article (PubMed ID: 36384886)
21. Glutamic acid decarboxylase and ICA512/IA-2 autoantibodies as disease markers and relationship to residual beta-cell function and glycemic control in young type 1 diabetic patients.
Zanone MM; Catalfamo E; Pietropaolo SL; Rabbone I; Sacchetti C; Cerutti F; Trucco M; Cavallo-Perin P
Metabolism; 2003 Jan; 52(1):25-9. PubMed ID: 12524658
[TBL] [Abstract][Full Text] [Related]
22. Type 1 diabetes and epilepsy in childhood and adolescence: Do glutamic acid decarboxylase autoantibodies play a role? Data from the German/Austrian/Swiss/Luxembourgian DPV Registry.
de Sousa GJ; Tittel SR; Häusler M; Holterhus PM; Berger G; Holder M; Kamrath C; Golembowski S; Herrlinger S; Holl RW
Pediatr Diabetes; 2020 Aug; 21(5):766-773. PubMed ID: 32333480
[TBL] [Abstract][Full Text] [Related]
23. Gender differences in GAD antibody-positive diabetes mellitus in relation to age at onset, C-peptide and other endocrine autoimmune diseases.
Lindholm E; Hallengren B; Agardh CD
Diabetes Metab Res Rev; 2004; 20(2):158-64. PubMed ID: 15037992
[TBL] [Abstract][Full Text] [Related]
24. Types of pediatric diabetes mellitus defined by anti-islet autoimmunity and random C-peptide at diagnosis.
Redondo MJ; Rodriguez LM; Escalante M; Smith EO; Balasubramanyam A; Haymond MW
Pediatr Diabetes; 2013 Aug; 14(5):333-40. PubMed ID: 23458188
[TBL] [Abstract][Full Text] [Related]
25. Beta cell function and ongoing autoimmunity in long-standing, childhood onset type 1 diabetes.
Williams GM; Long AE; Wilson IV; Aitken RJ; Wyatt RC; McDonald TJ; Wong FS; Hattersley AT; Williams AJ; Bingley PJ; Gillespie KM
Diabetologia; 2016 Dec; 59(12):2722-2726. PubMed ID: 27591853
[TBL] [Abstract][Full Text] [Related]
26. High frequency of persisting or increasing islet-specific autoantibody levels after diagnosis of type 1 diabetes presenting before 40 years of age. The Belgian Diabetes Registry.
Decochez K; Tits J; Coolens JL; Van Gaal L; Krzentowski G; Winnock F; Anckaert E; Weets I; Pipeleers DG; Gorus FK
Diabetes Care; 2000 Jun; 23(6):838-44. PubMed ID: 10841006
[TBL] [Abstract][Full Text] [Related]
27. Better HbA1c during the first years after diagnosis of type 1 diabetes is associated with residual C peptide 10 years later.
Grönberg A; Espes D; Carlsson PO
BMJ Open Diabetes Res Care; 2020 Feb; 8(1):. PubMed ID: 32107263
[TBL] [Abstract][Full Text] [Related]
28. High Residual β-cell Function in Chinese Patients With Autoimmune Type 1 Diabetes.
Wang Y; Qin Y; Gu H; Zhang L; Wang J; Huang Y; Shi Y; Hu Q; Chen Y; Gu Y; Shi Y; Tao Y; Zhang M
J Clin Endocrinol Metab; 2022 May; 107(6):e2348-e2358. PubMed ID: 35218654
[TBL] [Abstract][Full Text] [Related]
29. Residual β cell function in long-term type 1 diabetes associates with reduced incidence of hypoglycemia.
Gubitosi-Klug RA; Braffett BH; Hitt S; Arends V; Uschner D; Jones K; Diminick L; Karger AB; Paterson AD; Roshandel D; Marcovina S; Lachin JM; Steffes M; Palmer JP;
J Clin Invest; 2021 Feb; 131(3):. PubMed ID: 33529168
[TBL] [Abstract][Full Text] [Related]
30. Young age and HLA markers enhance the risk of progression to type 1 diabetes in antibody-positive siblings of diabetic children.
Yamamoto AM; Deschamps I; Garchon HJ; Roussely H; Moreau N; Beaurain G; Robert JJ; Bach JF
J Autoimmun; 1998 Dec; 11(6):643-50. PubMed ID: 9878086
[TBL] [Abstract][Full Text] [Related]
31. UKPDS 25: autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes. UK Prospective Diabetes Study Group.
Turner R; Stratton I; Horton V; Manley S; Zimmet P; Mackay IR; Shattock M; Bottazzo GF; Holman R
Lancet; 1997 Nov; 350(9087):1288-93. PubMed ID: 9357409
[TBL] [Abstract][Full Text] [Related]
32. Fasted C-Peptide Distribution and Associated Clinical Factors in Adults With Longstanding Type 1 Diabetes: Analysis of the Canadian Study of Longevity in Type 1 Diabetes.
Lanctôt SO; Lovblom LE; Lewis EJH; Morris M; Cardinez N; Scarr D; Bakhsh A; Abuabat MI; Lovshin JA; Lytvyn Y; Boulet G; Bussières A; Brent MH; Paul N; Bril V; Cherney DZI; Perkins BA
Can J Diabetes; 2024 Mar; 48(2):89-96. PubMed ID: 37944665
[TBL] [Abstract][Full Text] [Related]
33. Clinical characteristics, GAD antibody (GADA) and change of C-peptide in Korean young age of onset diabetic patients.
Ahn CW; Kim HS; Nam JH; Song YD; Lim SK; Kim KR; Lee HC; Huh KB
Diabet Med; 2002 Mar; 19(3):227-33. PubMed ID: 11918625
[TBL] [Abstract][Full Text] [Related]
34. Use of an islet cell antibody assay to identify type 1 diabetic patients with rapid decrease in C-peptide levels after clinical onset. Belgian Diabetes Registry.
Decochez K; Keymeulen B; Somers G; Dorchy H; De Leeuw IH; Mathieu C; Rottiers R; Winnock F; ver Elst K; Weets I; Kaufman L; Pipeleers DG; Gorus FK;
Diabetes Care; 2000 Aug; 23(8):1072-8. PubMed ID: 10937500
[TBL] [Abstract][Full Text] [Related]
35. The prevalence of early subclinical somatic neuropathy in children and adolescents with Type 1 diabetes mellitus and its association with the persistence of autoantibodies to glutamic acid decarboxylase (GAD) and islet antigen-2 (IA-2).
Louraki M; Katsalouli M; Kanaka-Gantenbein C; Kafassi N; Critselis E; Kallinikou D; Tsentidis C; Karavanaki K
Diabetes Res Clin Pract; 2016 Jul; 117():82-90. PubMed ID: 27329026
[TBL] [Abstract][Full Text] [Related]
36. Prevalence of autoantibodies in type 1 diabetes mellitus pediatrics in Mazandaran, North of Iran.
Zamanfar D; Aarabi M; Amini M; Monajati M
J Pediatr Endocrinol Metab; 2020 Aug; 33(10):1299-1305. PubMed ID: 32809953
[TBL] [Abstract][Full Text] [Related]
37. Beta-cell response to intravenous glucagon in African-American and Hispanic children with type 2 diabetes mellitus.
Taha DR; Castells S; Umpaichitra V; Bastian W; Banerji MA
J Pediatr Endocrinol Metab; 2002 Jan; 15(1):59-67. PubMed ID: 11822582
[TBL] [Abstract][Full Text] [Related]
38. Ketoacidosis in young adults is not related to the islet antibodies at the diagnosis of Type 1 diabetes mellitus--a nationwide study.
Ostman J; Landin-Olsson M; Törn C; Palmer J; Lernmark A; Arnqvist H; Björk E; Bolinder J; Blohmé G; Eriksson J; Littorin B; Nyström L; Scherstén B; Sundkvist G; Wibell L
Diabet Med; 2000 Apr; 17(4):269-74. PubMed ID: 10821292
[TBL] [Abstract][Full Text] [Related]
39. GAD65 antigen therapy in recently diagnosed type 1 diabetes mellitus.
Ludvigsson J; Krisky D; Casas R; Battelino T; Castaño L; Greening J; Kordonouri O; Otonkoski T; Pozzilli P; Robert JJ; Veeze HJ; Palmer J; Samuelsson U; Elding Larsson H; Åman J; Kärdell G; Neiderud Helsingborg J; Lundström G; Albinsson E; Carlsson A; Nordvall M; Fors H; Arvidsson CG; Edvardson S; Hanås R; Larsson K; Rathsman B; Forsgren H; Desaix H; Forsander G; Nilsson NÖ; Åkesson CG; Keskinen P; Veijola R; Talvitie T; Raile K; Kapellen T; Burger W; Neu A; Engelsberger I; Heidtmann B; Bechtold S; Leslie D; Chiarelli F; Cicognani A; Chiumello G; Cerutti F; Zuccotti GV; Gomez Gila A; Rica I; Barrio R; Clemente M; López Garcia MJ; Rodriguez M; Gonzalez I; Lopez JP; Oyarzabal M; Reeser HM; Nuboer R; Stouthart P; Bratina N; Bratanic N; de Kerdanet M; Weill J; Ser N; Barat P; Bertrand AM; Carel JC; Reynaud R; Coutant R; Baron S
N Engl J Med; 2012 Feb; 366(5):433-42. PubMed ID: 22296077
[TBL] [Abstract][Full Text] [Related]
40. Clinical characteristics, and time course of pancreatic beta-cell function and glutamic acid decarboxylase antibodies in Thai patients with adult-onset Type 1 diabetes: distinction between patients of rapid- and slow-onset.
Rattarasarn C; Diosdado MA
Horm Metab Res; 1999 May; 31(5):311-6. PubMed ID: 10422726
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
